Free Trial

Maase (MAAS) Competitors

Maase logo
$14.86 +2.02 (+15.73%)
Closing price 06/12/2026 04:00 PM Eastern
Extended Trading
$13.87 -0.99 (-6.66%)
As of 06/12/2026 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

MAAS vs. FBRT, TRTX, PSTL, VINP, and BBOT

Should you buy Maase stock or one of its competitors? MarketBeat compares Maase with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Maase include Franklin BSP Realty Trust (FBRT), TPG RE Finance Trust (TRTX), Postal Realty Trust (PSTL), Vinci Compass Investments (VINP), and BridgeBio Oncology Therapeutics (BBOT). These companies are all part of the "trading" industry.

How does Maase compare to Franklin BSP Realty Trust?

Franklin BSP Realty Trust (NYSE:FBRT) and Maase (NASDAQ:MAAS) are both small-cap trading companies, but which is the better investment? We will compare the two companies based on the strength of their risk, media sentiment, valuation, dividends, analyst recommendations, earnings, profitability and institutional ownership.

Franklin BSP Realty Trust has a net margin of 24.26% compared to Maase's net margin of 0.00%. Franklin BSP Realty Trust's return on equity of 6.46% beat Maase's return on equity.

Company Net Margins Return on Equity Return on Assets
Franklin BSP Realty Trust24.26% 6.46% 1.34%
Maase N/A N/A N/A

59.9% of Franklin BSP Realty Trust shares are held by institutional investors. 1.3% of Franklin BSP Realty Trust shares are held by insiders. Comparatively, 87.6% of Maase shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Franklin BSP Realty Trust has a beta of 0.92, indicating that its share price is 8% less volatile than the broader market. Comparatively, Maase has a beta of 0.07, indicating that its share price is 93% less volatile than the broader market.

In the previous week, Maase had 2 more articles in the media than Franklin BSP Realty Trust. MarketBeat recorded 2 mentions for Maase and 0 mentions for Franklin BSP Realty Trust. Franklin BSP Realty Trust's average media sentiment score of 1.55 beat Maase's score of 0.94 indicating that Franklin BSP Realty Trust is being referred to more favorably in the media.

Company Overall Sentiment
Franklin BSP Realty Trust Very Positive
Maase Positive

Franklin BSP Realty Trust presently has a consensus target price of $11.50, indicating a potential upside of 37.64%. Given Franklin BSP Realty Trust's stronger consensus rating and higher possible upside, equities research analysts clearly believe Franklin BSP Realty Trust is more favorable than Maase.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Franklin BSP Realty Trust
2 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.20
Maase
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Franklin BSP Realty Trust has higher earnings, but lower revenue than Maase.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Franklin BSP Realty Trust$270.07M2.38$82.27M$0.5116.38
Maase$781.22M0.30-$27.36MN/AN/A

Summary

Franklin BSP Realty Trust beats Maase on 11 of the 14 factors compared between the two stocks.

How does Maase compare to TPG RE Finance Trust?

TPG RE Finance Trust (NYSE:TRTX) and Maase (NASDAQ:MAAS) are both small-cap trading companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, institutional ownership, media sentiment, valuation, earnings, dividends, analyst recommendations and risk.

TPG RE Finance Trust currently has a consensus target price of $9.83, suggesting a potential upside of 14.41%. Given TPG RE Finance Trust's stronger consensus rating and higher possible upside, research analysts clearly believe TPG RE Finance Trust is more favorable than Maase.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
TPG RE Finance Trust
0 Sell rating(s)
2 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.67
Maase
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

TPG RE Finance Trust has a net margin of 19.38% compared to Maase's net margin of 0.00%. TPG RE Finance Trust's return on equity of 6.91% beat Maase's return on equity.

Company Net Margins Return on Equity Return on Assets
TPG RE Finance Trust19.38% 6.91% 1.74%
Maase N/A N/A N/A

TPG RE Finance Trust has a beta of 1.41, indicating that its stock price is 41% more volatile than the broader market. Comparatively, Maase has a beta of 0.07, indicating that its stock price is 93% less volatile than the broader market.

TPG RE Finance Trust has higher earnings, but lower revenue than Maase.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
TPG RE Finance Trust$332.58M2.00$60.32M$0.6313.64
Maase$781.22M0.30-$27.36MN/AN/A

In the previous week, TPG RE Finance Trust had 1 more articles in the media than Maase. MarketBeat recorded 3 mentions for TPG RE Finance Trust and 2 mentions for Maase. Maase's average media sentiment score of 0.94 beat TPG RE Finance Trust's score of 0.67 indicating that Maase is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
TPG RE Finance Trust
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Maase
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

57.1% of TPG RE Finance Trust shares are owned by institutional investors. 3.0% of TPG RE Finance Trust shares are owned by insiders. Comparatively, 87.6% of Maase shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Summary

TPG RE Finance Trust beats Maase on 11 of the 14 factors compared between the two stocks.

How does Maase compare to Postal Realty Trust?

Postal Realty Trust (NYSE:PSTL) and Maase (NASDAQ:MAAS) are both small-cap trading companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, media sentiment, risk, valuation, institutional ownership, earnings, analyst recommendations and profitability.

Postal Realty Trust has higher earnings, but lower revenue than Maase.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Postal Realty Trust$95.82M6.87$14.15M$0.5146.74
Maase$781.22M0.30-$27.36MN/AN/A

Postal Realty Trust has a beta of 0.79, suggesting that its stock price is 21% less volatile than the broader market. Comparatively, Maase has a beta of 0.07, suggesting that its stock price is 93% less volatile than the broader market.

Postal Realty Trust has a net margin of 15.84% compared to Maase's net margin of 0.00%. Postal Realty Trust's return on equity of 4.53% beat Maase's return on equity.

Company Net Margins Return on Equity Return on Assets
Postal Realty Trust15.84% 4.53% 2.14%
Maase N/A N/A N/A

Postal Realty Trust presently has a consensus price target of $23.54, suggesting a potential downside of 1.23%. Given Postal Realty Trust's stronger consensus rating and higher possible upside, equities research analysts clearly believe Postal Realty Trust is more favorable than Maase.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Postal Realty Trust
0 Sell rating(s)
2 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.75
Maase
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

In the previous week, Maase had 1 more articles in the media than Postal Realty Trust. MarketBeat recorded 2 mentions for Maase and 1 mentions for Postal Realty Trust. Postal Realty Trust's average media sentiment score of 1.00 beat Maase's score of 0.94 indicating that Postal Realty Trust is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Postal Realty Trust
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Maase
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

57.9% of Postal Realty Trust shares are held by institutional investors. 12.5% of Postal Realty Trust shares are held by insiders. Comparatively, 87.6% of Maase shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Summary

Postal Realty Trust beats Maase on 11 of the 14 factors compared between the two stocks.

How does Maase compare to Vinci Compass Investments?

Maase (NASDAQ:MAAS) and Vinci Compass Investments (NASDAQ:VINP) are both small-cap trading companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, valuation, analyst recommendations, profitability, risk, media sentiment, earnings and institutional ownership.

Vinci Compass Investments has lower revenue, but higher earnings than Maase.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Maase$781.22M0.30-$27.36MN/AN/A
Vinci Compass Investments$175.01M3.64$38.97M$0.7413.18

In the previous week, Vinci Compass Investments had 11 more articles in the media than Maase. MarketBeat recorded 13 mentions for Vinci Compass Investments and 2 mentions for Maase. Maase's average media sentiment score of 0.94 beat Vinci Compass Investments' score of 0.68 indicating that Maase is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Maase
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Vinci Compass Investments
7 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Vinci Compass Investments has a consensus price target of $14.00, indicating a potential upside of 43.59%. Given Vinci Compass Investments' stronger consensus rating and higher probable upside, analysts clearly believe Vinci Compass Investments is more favorable than Maase.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Maase
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Vinci Compass Investments
0 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.75

34.1% of Vinci Compass Investments shares are owned by institutional investors. 87.6% of Maase shares are owned by insiders. Comparatively, 49.3% of Vinci Compass Investments shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Vinci Compass Investments has a net margin of 26.75% compared to Maase's net margin of 0.00%. Vinci Compass Investments' return on equity of 13.73% beat Maase's return on equity.

Company Net Margins Return on Equity Return on Assets
MaaseN/A N/A N/A
Vinci Compass Investments 26.75%13.73%7.32%

Maase has a beta of 0.07, indicating that its stock price is 93% less volatile than the broader market. Comparatively, Vinci Compass Investments has a beta of 0.29, indicating that its stock price is 71% less volatile than the broader market.

Summary

Vinci Compass Investments beats Maase on 11 of the 14 factors compared between the two stocks.

How does Maase compare to BridgeBio Oncology Therapeutics?

BridgeBio Oncology Therapeutics (NASDAQ:BBOT) and Maase (NASDAQ:MAAS) are both small-cap financial services companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, profitability, valuation, media sentiment, earnings, dividends and risk.

BridgeBio Oncology Therapeutics has a beta of 0.29, meaning that its stock price is 71% less volatile than the broader market. Comparatively, Maase has a beta of 0.07, meaning that its stock price is 93% less volatile than the broader market.

Maase has higher revenue and earnings than BridgeBio Oncology Therapeutics.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BridgeBio Oncology TherapeuticsN/AN/A-$134.04M-$2.05N/A
Maase$781.22M0.30-$27.36MN/AN/A

BridgeBio Oncology Therapeutics currently has a consensus price target of $25.00, indicating a potential upside of 222.58%. Given BridgeBio Oncology Therapeutics' stronger consensus rating and higher probable upside, equities analysts clearly believe BridgeBio Oncology Therapeutics is more favorable than Maase.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
BridgeBio Oncology Therapeutics
1 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.60
Maase
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Company Net Margins Return on Equity Return on Assets
BridgeBio Oncology TherapeuticsN/A N/A N/A
Maase N/A N/A N/A

In the previous week, BridgeBio Oncology Therapeutics had 11 more articles in the media than Maase. MarketBeat recorded 13 mentions for BridgeBio Oncology Therapeutics and 2 mentions for Maase. Maase's average media sentiment score of 0.94 beat BridgeBio Oncology Therapeutics' score of 0.03 indicating that Maase is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
BridgeBio Oncology Therapeutics
0 Very Positive mention(s)
0 Positive mention(s)
10 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Neutral
Maase
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

54.9% of BridgeBio Oncology Therapeutics shares are owned by institutional investors. 24.4% of BridgeBio Oncology Therapeutics shares are owned by company insiders. Comparatively, 87.6% of Maase shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Summary

BridgeBio Oncology Therapeutics beats Maase on 6 of the 10 factors compared between the two stocks.

Get Maase News Delivered to You Automatically

Sign up to receive the latest news and ratings for MAAS and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MAAS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MAAS vs. The Competition

MetricMaaseSecurity And Commodity Brokers, Dealers, Exchanges & Services IndustryFinancial SectorNASDAQ Exchange
Market Cap$236.53M$2.34B$5.89B$12.07B
Dividend YieldN/A0.74%5.30%5.66%
P/E RatioN/A15.6116.3524.42
Price / Sales0.3011.191,104.22108.00
Price / CashN/A10.0489.5655.64
Price / Book0.792.416.576.80
Net Income-$27.36M$15.01M$1.13B$338.00M
7 Day Performance39.40%4.32%1.17%2.68%
1 Month Performance46.55%-7.54%1.09%1.55%
1 Year PerformanceN/A10.72%20.39%30.59%

Maase Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MAAS
Maase
0.3005 of 5 stars
$14.86
+15.7%
N/AN/A$236.53M$781.22MN/A550
FBRT
Franklin BSP Realty Trust
4.6437 of 5 stars
$8.39
-2.2%
$11.50
+37.1%
-22.8%$645.34M$498.69M16.44N/A
TRTX
TPG RE Finance Trust
4.1996 of 5 stars
$8.32
-2.2%
$9.83
+18.3%
+8.2%$642.82M$151.45M13.20N/A
PSTL
Postal Realty Trust
2.8931 of 5 stars
$22.80
+0.2%
$22.71
-0.4%
+59.1%$629.69M$100.32M44.7040
VINP
Vinci Compass Investments
4.8192 of 5 stars
$9.61
0.0%
$14.00
+45.7%
+3.7%$628.64M$1.02B12.99240

Related Companies and Tools


This page (NASDAQ:MAAS) was last updated on 6/14/2026 by MarketBeat.com Staff.
From Our Partners